|
"jia horng kao"的相關文件
顯示項目 936-985 / 1180 (共24頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Optimal management of hepatocellular carcinoma: Challenges and opportunities
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Outcomes of HCV treatment: Who does well and who does not?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Preoperative drainage in pancreatic cancer
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Clinical implications of hepatitis B virus variants
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
|
Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
From liver markers to life expectancy
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection
|
Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward; JIA-HORNG KAO; Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C infection and metabolic syndrome.
|
JIA-HORNG KAO; Hsu, C.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
|
Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell; JIA-HORNG KAO; Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A novel antibody associated with autoimmune pancreatitis [4]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Carvedilol versus variceal band ligation for prevention of the first variceal bleed
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Metabolic syndrome on top of chronic hepatitis B: The more, the worse?
|
Chang, L.-C.;Chung, C.-S.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:40Z |
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects
|
Kao, J.-H.;Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:47Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S. and Liu, C.-H. and Liu, C.-J. and Hsu, S.-J. and Chen, C.-L. and Hwang, J.-J. and Lai, M.-Y. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; JUEY-JEN HWANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:44Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su, T.-H. and Hsu, C.-S. and Chen, C.-L. and Liu, C.-H. and Huang, Y.-W. and Tseng, T.-C. and Liu, C.-J. and Chen, P.-J. and Lai, M.-Y. and Chen, D.-S. and Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:10:19Z |
Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation
|
Huang, Z.-S.;Huang, T.-S.;Wu, T.-H.;Chen, M.-F.;Hsu, C.-S.;Kao, J.-H.; ZEI-SHUNG HUANG; TIEN-SHANG HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:53Z |
Recent advances in clinical application of gut hormones
|
Tseng, P.-H. and Wu, M.-S. and Kao, J.-H.; PING-HUEI TSENG; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:10Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu, M.-L. and Lee, C.-M. and Chuang, W.-L. and Lu, S.-N. and Dai, C.-Y. and Huang, J.-F. and Lin, Z.-Y. and Hu, T.-I. and Chen, C.-H. and Hung, C.-. and Wang, J.-H. and Chen, C.-L. and Kao, J.-H. and Lai, M.-Y. and Liu, C.-H. and Su, T.-H. and Wu, S.-S. and Liao, L.-Y. and Kuo, H.-T. and Chao, Y.-C. and Tung, S.-Y. and Yang, S.-S. and Chen, P.-J. and Liu, C.-J. and Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease?
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice
|
Kao, J.-H.;Heptonstall, J.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan
|
Kao, J.-H.;Chen, W.;Hsiang, S.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients
|
Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H.; JIA-HORNG KAO; Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Prevention of hepatocellular carcinoma in hepatitis B virus infection
|
Lim, S.G.;Mohammed, R.;Yuen, M.-F.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
|
Wang, Chia-Chi;Lin, Shinn-Kuang;Tseng, Yuan-Fu;Hsu, Ching-Sheng;Tseng, Tai-Chung;Lin, Hans Hsien-Hong;Wang, Li-Yu;Kao, Jia-Horng; JIA-HORNG KAO; WANG, CHIA-CHI; LIN, SHINN-KUANG; TSENG, YUAN-FU; HSU, CHING-SHENG; TSENG, TAI-CHUNG; LIN, HANS HSIEN-HONG; WANG, LI-YU; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Esomeprazole for asthma [7]
|
Hsu, Ching-Sheng;Kao, Jia-Horng; JIA-HORNG KAO; HSU, CHING-SHENG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis
|
Tong, Myron John; Hsien, Carlos; Song, Joanna Jungeun; Kao, Jia Horng; Sun, Hai-En; Hsu, Leeyen; Han, Steven-Huy; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell; JIA-HORNG KAO; Tong, Myron John; Hsien, Carlos; Song, Joanna Jungeun; Kao, Jia Horng; Sun, Hai-En; Hsu, Leeyen; Han, Steven-Huy; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBsAg Seroclearance: The More and Earlier, the Better
|
Tseng, Tai-Chung;Kao, Jia-Horng; JIA-HORNG KAO; TSENG, TAI-CHUNG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy
|
Tseng, Tai-Chung;Liu, Chun-Jen;Hsieh, San-Chia;Chen, Pei-Jer;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO; TSENG, TAI-CHUNG; LIU, CHUN-JEN; HSIEH, SAN-CHIA; CHEN, PEI-JER; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease
|
Hsu, Ching-Sheng;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Capsule endoscopy versus colonoscopy
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication
|
Kao, J.-H.; Chen, W.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:33Z |
Comparison of two methods for quantification of hepatitis B viral DNA
|
Kao, J.-H.; Wood, M.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:34Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu, Chun-Jen;Jeng, Yung-Ming;Chen, Chi-Ling;Chen, Pei-Jer;Chen, Ting-Chi;Liu, Chen-Hua;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; YUNG-MING JENG; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, TING-CHI; LIU, CHEN-HUA; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus
|
PEI-JER CHEN; CHUNG-YI HU; DING-SHINN CHEN; JIA-HORNG KAO; HUANG, YI-WEN; HU, CHUNG-YI; CHEN, CHI-LING; LIAO, YA-TANG; LIU, CHUN-JEN; LAI, MING-YANG; CHEN, PEI-JER; YANG, SIEN-SING; HU, JUI-TING; CHEN, DING-SHINN; KAO, JIA-HORNG; CHUN-JEN LIU; Huang, Yi-Wen;Hu, Chung-Yi;Chen, Chi-Ling;Liao, Ya-Tang;Liu, Chun-Jen;Lai, Ming-Yang;Chen, Pei-Jer;Yang, Sien-Sing;Hu, Jui-Ting;Chen, Ding-Shinn;Kao, Jia-Horng; YI-WEN HUANG |
顯示項目 936-985 / 1180 (共24頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
|
